TesoRx Pharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 3

TesoRx Pharma General Information

Description

Developer of biopharmaceutical therapies designed to focus on endocrinology, oncology, and other specialty areas. The company offers a proprietary drug delivery platform anchored by a clinically validated oral testosterone candidate that enables consistent, physiologic hormone absorption and improves the bioavailability of challenging molecules such as hormones and lipophilic small molecules, enabling the development of versatile treatments and expanding therapeutic options across multiple categories.

Contact Information

Website
www.tesorx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 325 Sharon Park Drive
  • Suite 739
  • Menlo Park, CA 94025
  • United States
+1 (650)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Pharmaceuticals
Other Healthcare Technology Systems
Corporate Office
  • 325 Sharon Park Drive
  • Suite 739
  • Menlo Park, CA 94025
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TesoRx Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 11-Aug-2025 Cancelled Clinical Trials - Phase 1
9. Later Stage VC 03-May-2019 Completed Clinical Trials - Phase 1
8. Later Stage VC 01-Dec-2017 Completed Clinical Trials - Phase 1
7. Later Stage VC 13-Jul-2016 Completed Clinical Trials - Phase 1
6. Early Stage VC 20-Oct-2014 Completed Clinical Trials - Phase 1
5. Early Stage VC (Series B1) 05-Aug-2014 Completed Clinical Trials - Phase 1
4. Seed Round 30-Jul-2013 Completed Clinical Trials - Phase 1
3. Seed Round 31-Dec-2012 Completed Clinical Trials - Phase 1
2. Seed Round 11-Jul-2012 $5.92M $10.9M Completed Pre-Clinical Trials
1. Capitalization 31-Dec-2010 $5M $5M Completed Pre-Clinical Trials
To view TesoRx Pharma’s complete valuation and funding history, request access »

TesoRx Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceutical therapies designed to focus on endocrinology, oncology, and other specialty areas. The co
Drug Delivery
Menlo Park, CA
4 As of 2025

San Diego, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TesoRx Pharma Competitors (33)

One of TesoRx Pharma’s 33 competitors is Halozyme Therapeutics, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Halozyme Therapeutics Formerly VC-backed San Diego, CA
Entrada Therapeutics Formerly VC-backed Boston, MA
BeOne Medicines Formerly PE-Backed Beijing, China
Inventiva (Drug Discovery) Corporation Daix, France
Regenxbio Formerly VC-backed Rockville, MD
You’re viewing 5 of 33 competitors. Get the full list »

TesoRx Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TesoRx Pharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
ASKA Pharmaceutical Holdings Corporation Minority
Aspen Global Corporation Minority
Keiretsu Forum Angel Group Minority
To view TesoRx Pharma’s complete investors history, request access »

TesoRx Pharma Investments (1)

TesoRx Pharma’s most recent deal was a Joint Venture with Production Joint Venture for TSX-002 ( CoreRx / TesoRx Pharma). The deal was made on 28-Aug-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Production Joint Venture for TSX-002 ( CoreRx / TesoRx Pharma) 28-Aug-2013 Joint Venture Drug Delivery
To view TesoRx Pharma’s complete investments history, request access »

TesoRx Pharma FAQs

  • When was TesoRx Pharma founded?

    TesoRx Pharma was founded in 2010.

  • Where is TesoRx Pharma headquartered?

    TesoRx Pharma is headquartered in Menlo Park, CA.

  • What is the size of TesoRx Pharma?

    TesoRx Pharma has 4 total employees.

  • What industry is TesoRx Pharma in?

    TesoRx Pharma’s primary industry is Drug Delivery.

  • Is TesoRx Pharma a private or public company?

    TesoRx Pharma is a Private company.

  • What is TesoRx Pharma’s current revenue?

    The current revenue for TesoRx Pharma is .

  • How much funding has TesoRx Pharma raised over time?

    TesoRx Pharma has raised $134M.

  • Who are TesoRx Pharma’s investors?

    ASKA Pharmaceutical Holdings, Aspen Global, and Keiretsu Forum have invested in TesoRx Pharma.

  • Who are TesoRx Pharma’s competitors?

    Halozyme Therapeutics, Entrada Therapeutics, BeOne Medicines, Inventiva (Drug Discovery), and Regenxbio are some of the 33 competitors of TesoRx Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process